CJC-1295 (No DAC) + Ipamorelin

This research blend pairs CJC-1295 (No DAC) — a short-acting GHRH analog, also known as Modified GRF 1-29 — with Ipamorelin, a selective ghrelin-receptor secretagogue. Together they’re among the most-studied growth-hormone secretagogue combinations in the literature.

Why these two, and why No DAC
The pairing engages GH release through two complementary receptor systems at once: CJC-1295 acts on the GHRH receptor, Ipamorelin on the ghrelin receptor — often framed as “pressing the accelerator” (GHRH) while “releasing the brake” (ghrelin pathway). The No-DAC form of CJC-1295 is short-acting rather than sustained, producing a pulsatile profile that more closely mimics the body’s natural GH rhythm — the reason this form (not the multi-day DAC version) is the one typically studied in the combination.

Research context
This is a research-grade blend supplied for in-vitro and laboratory study only. Both components are investigational and not FDA-approved, and GH secretagogues are prohibited in sport under the WADA Prohibited List (Section S2). For full mechanism and literature, see our CJC-1295 Research Overview »

Prefer the components on their own? We also supply standalone CJC-1295 (Without DAC)  and Ipamorelin

Purity & testing
– ≥99% purity (this lot: 99.68% by HPLC)
– Lyophilized powder for laboratory reconstitution
– Batch-specific Certificate of Analysis — HPLC + mass spec, heavy metals, sterility, endotoxin
– ISO/IEC 17025-accredited third-party testing → View the COA »

Laboratory handling
Store lyophilized material cold and protected from light (long-term at −20 °C). After reconstitution, refrigerate at 2–8 °C and use within your protocol window. Confirm identity and purity against the batch COA before use.

Research FAQ
Why the No-DAC form instead of DAC? No-DAC (Mod GRF 1-29) is short-acting and pulsatile; the DAC form has a multi-day half-life and sustained profile. The pulsatile form is the one typically paired with Ipamorelin.
Why combine CJC-1295 with Ipamorelin? They act on different receptors (GHRH vs ghrelin), so they’re studied together for a complementary effect on GH pulsatility.

For laboratory and research use only. Not for human or veterinary consumption, and not for diagnostic or therapeutic use. These statements have not been evaluated by the FDA.